GxP series Industry standards (GLP/GCP/GMP)
GxP (Good … Practice) is a worldwide recognized quality assurance system for pharmaceutical products. The GxP system covers all stages of the pharmaceutical product life cycle, from pharmaceutical development, testing, manufacturing, storage to use by the end consumer, namely:
- preclinical (laboratory) trials regulated by GLP (Good Laboratory Practice);
- clinical trials regulated by GCP (Good Clinical Practice);
- manufacturing regulated by GMP (Good Manufacturing Practice);
- storage regulated by GSP (Good Service Practice);
- wholesale regulated by GDP (Good Distribution Practice);
- retail, regulated by GPP (Good Participatory Practice).
Russian Register provides certification services for compliance with the following GxP standards: GLP, GCP and GMP.
GLP. Good Laboratory Practice
GLP (Good Laboratory Practice) is a quality system, concerned with the organizational process and conditions under which non-clinical health and environmental safety pharmaceutical product studies are performed.
GLP principles include:
- requirements for the test organization;
- requirements for personnel conducting the trials;
- requirements for premises where test are conducted and animals are kept;
- requirements for animal quality, their feed and bedding;
- requirements for laboratory equipment and equipment calibration;
- requirements for test and reference item;
- requirements for the compilation and implementation of a detailed standard methodology for experimental work and performance of the study;
- requirements for data recording and reporting;
- requirements for testing quality control service;
- standard operating procedures.

GOST 33044–2014, the Interstate Standard “Principles of Good Laboratory Practice” is a national equivalent of GLP in Russian Federation with the text identical to GLP.
GСP. Good Clinical Practice
GCP (Good Clinical Practice) is an international ethical and scientific standard for planning and conducting the trials involving human subjects, as well as for documenting and presenting the results of such trials.
GCP rules are developed to ensure the reliability of clinical trials, as well as safety and protection of the rights and health of the people participating in these trials as subjects.
GOST R 52379–2005 “Good Clinical Practice” is a national equivalent of GCP in Russian Federation with the text identical to GСP.
GMP. Good Manufacturing Practice
GMP (Good Manufacturing Practice) is an international standard that establishes requirements for the manufacturing and quality control of pharmaceutical products for humans and animals, as well as special requirements for the manufacturing of active pharmaceutical ingredients and certain types of pharmaceutical products. The GMP standard regulates and evaluates manufacturing and laboratory trials parameters.
GOST R 52249–2009 “Good Manufacturing Practice for medicinal products” is a national equivalent of GMP in Russian Federation with the text identical to GMP.
Benefits of implementation and certification
- improving quality and evidence of preclinical and clinical trials during the development of new active pharmaceutical ingredients and pharmaceutical products;
- ensuring quality, safety and effectiveness of pharmaceutical products and active pharmaceutical ingredients during their manufacturing;
- enhancing image of the organization, demonstrating adherence to the requirements of international standards, best practices, product quality and compliance with applicable legislative and regulatory requirements;
- ensuring economic sustainability of the organization on the existing market of medical devices manufacturers and the opportunity to enter new markets;
- increasing commercial products value in terms of greater consumer confidence and, as a consequence, increase sales volume;
- contribution to successful participation in tenders’ procedure, competitions for the products supply to an organization;
- clear alignment of the organization’s business processes, efficient distribution of internal resources, responsibilities and authorities of personnel within the existing management system;
- opportunity to export pharmaceutical products to the countries of the Eurasian Economic Union and European Union.